(2026). Do the treatment selection factors emphasized in clinical guidelines—Chronic kidney disease, cardiovascular disease, and heart failure—contribute to the risk of urinary tract infections during the administration of sodium‐glucose cotransporter‐2 inhibitors? Journal of Diabetes Investigation.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Do the Treatment Selection Factors Emphasized in Clinical Guidelines—Chronic Kidney Disease, Cardiovascular Disease, and Heart Failure—contribute to the Risk of Urinary Tract Infections During the Administration of Sodium‐glucose Cotransporter‐2 Inhibitors?"
Journal of Diabetes Investigation 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Do the Treatment Selection Factors Emphasized in Clinical Guidelines—Chronic Kidney Disease, Cardiovascular Disease, and Heart Failure—contribute to the Risk of Urinary Tract Infections During the Administration of Sodium‐glucose Cotransporter‐2 Inhibitors?"
Journal of Diabetes Investigation, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.